Company / Operating Cash Flow per Share
Beam Therapeutics Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.39
FY2025
5-year range
-$4.15 / $0.32
FY2021-FY2025
Trend
+18.3%
vs FY2024
Sector context
#175 of 212
Health Care
What the data says
Beam Therapeutics Inc.'s operating cash flow per share of $-3.39 is lower than 83% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-3.39.
Based on SEC 10-K filings.
-3.39 in FY2025.
Declined from $-1.83 to $-3.39 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 212This company -$3.39 Sector average -$14.72
▼
+77.0% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 18.3% year-over-year.
- Ranks #175 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.39 | +18.3% |
| FY2024 | -$4.15 | -127.2% |
| FY2023 | -$1.83 | -678.3% |
| FY2022 | $0.32 | +132.6% |
| FY2021 | -$0.97 | +90.1% |
| FY2020 | -$9.83 | +11.6% |
| FY2019 | -$11.11 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026